Does DEXCHLORPHENIRAMINE Cause Interstitial lung disease? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Interstitial lung disease have been filed in association with DEXCHLORPHENIRAMINE (RYCLORA). This represents 0.9% of all adverse event reports for DEXCHLORPHENIRAMINE.
15
Reports of Interstitial lung disease with DEXCHLORPHENIRAMINE
0.9%
of all DEXCHLORPHENIRAMINE reports
1
Deaths
14
Hospitalizations
How Dangerous Is Interstitial lung disease From DEXCHLORPHENIRAMINE?
Of the 15 reports, 1 (6.7%) resulted in death, 14 (93.3%) required hospitalization.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DEXCHLORPHENIRAMINE. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does DEXCHLORPHENIRAMINE Cause?
Erythema (198)
Hypersensitivity (189)
Dyspnoea (147)
Hypotension (115)
Nausea (107)
Malaise (100)
Acute kidney injury (84)
Rash (71)
Off label use (67)
Drug ineffective (65)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which DEXCHLORPHENIRAMINE Alternatives Have Lower Interstitial lung disease Risk?
DEXCHLORPHENIRAMINE vs DEXKETOPROFEN
DEXCHLORPHENIRAMINE vs DEXKETOPROFEN TROMETAMOL
DEXCHLORPHENIRAMINE vs DEXLANSOPRAZOLE
DEXCHLORPHENIRAMINE vs DEXMEDETOMIDINE
DEXCHLORPHENIRAMINE vs DEXMETHYLPHENIDATE